2025

December

• Dec 24th, 2025

  Notice Concerning the Cancellation of Treasury Shares[English Disclosure Information]

November

• Nov 18th, 2025

  Notice Concerning the Status and Program Completion of Repurchase of Own Shares[English Disclosure Information]

• Nov 14th, 2025

  Ajinomoto Co., Inc. and Forge Biologics Develops Culture Media Supplements to Improve Productivity of Gene Therapy Products

• Nov 6th, 2025

  Consolidated Financial Results for the Six Months Ended September 30, 2025[English Disclosure Information]

• Nov 6th, 2025

  Notice Concerning Determination of Matters Related to Repurchase of Own Shares[English Disclosure Information]

• Nov 5th, 2025

  Notice Concerning Progress on Repurchase of Own Shares[English Disclosure Information]

October

• Oct 31st, 2025

  Ajinomoto Co., Inc. Enters Licensing Agreement with Astellas Pharma Inc. for Biopharmaceutical Development and Manufacturing Technology

• Oct 14th, 2025

  Ajinomoto Co., Inc. Files Patent Infringement Suits in China and Japan Regarding Its Manufacturing Process for Monosodium Glutamate (MSG) Products

• Oct 2nd, 2025

  Notice Concerning Progress on Repurchase of Own Shares[English Disclosure Information]

September

• Sep 2nd, 2025

  Notice Concerning Progress on Repurchase of Own Shares[English Disclosure Information]

August

• Aug 28th, 2025

  Ajinomoto Co., Inc. to Build a New Factory at Ajinomoto Philippines Corporation

• Aug 7th, 2025

  Ajinomoto Co., Inc. Invests in v2food Pty Ltd, an Innovator in Next-Generation Sustainable Foods

• Aug 4th, 2025

  Consolidated Financial Results for the Three Months Ended June 30, 2025[English Disclosure Information]

• Aug 4th, 2025

  Notice Concerning Progress on Repurchase of Own Shares[English Disclosure Information]

July

• Jul 10th, 2025

  Ajinomoto Co., Inc. Launches Joint Project with OECD to Help Promote Well-being

• Jul 2nd, 2025

  Notice Concerning Progress on Repurchase of Own Shares[English Disclosure Information]

June

• Jun 13th, 2025

  Ajinomoto Co., Inc. Invests in Somite Therapeutics Inc., an AI Platform Startup Optimizing iPS Cell Differentiation

• Jun 12th, 2025

  Ajinomoto Co., Inc. Earns EcoVadis Gold Sustainability Rating for Two Consecutive Years

• Jun 3rd, 2025

  Notice Concerning Progress on Repurchase of Own Shares[English Disclosure Information]

• Jun 2nd, 2025

  Ajinomoto Co., Inc. Selected as Digital Transformation Stock 2025

May

• May 27th, 2025

  Ajinomoto Group Develops Japan’s First Nutrient Profiling System for Meals

• May 14th, 2025

  Ajinomoto Co., Inc. Selected as Sustainability Transformation Brand 2025

• May 13th, 2025

  Ajinomoto Co., Inc. Announces the Group’s Personnel Change

• May 9th, 2025

  Notice Concerning Results of Repurchase of Own Shares Through Off_Auction Own Share Repurchase Trading System (ToSTNeT_3)[English Disclosure Information]

• May 8th, 2025

  Notice Concerning Repurchase of Own Shares Through Off_Auction Own Share Repurchase Trading System (ToSTNeT_3)[English Disclosure Information]

• May 8th, 2025

  Notice Concerning Determination of Matters Related to Repurchase of Own Shares[English Disclosure Information]

• May 8th, 2025

  Notice Concerning Transfer of Non current Assets[English Disclosure Information]

• May 8th, 2025

  Consolidated Financial Results for the Fiscal Year Ended March 31, 2025[English Disclosure Information]

April

• Apr 24th, 2025

  Ajinomoto Co., Inc. to Sell* its Entire Equity Stake in Ajinomoto Althea, a US-based Aseptic Fill-Finish CDMO

• Apr 24th, 2025

  Notice of Change in a Consolidated Subsidiary (Share Transfer)[English Disclosure Information]

• Apr 24th, 2025

  Notice of Revision to Full-Year Consolidated Performance Forecast, Variances between Non-Consolidated Performance Estimates and Previous Fiscal Year’s Actual Results, and Recording of Other Operating Expense (Consolidated) and Extraordinary Loss (Non-Consolidated)[English Disclosure Information]

• Apr 18th, 2025

  Ajinomoto Co., Inc. Invests in Impact Investment Fund Managed by U.S. Investment Firm

• Apr 18th, 2025

  Ajinomoto Co., Inc. Named to CDP’s Climate Change A List for Five Consecutive Years

March

• Mar 27th, 2025

  Ajinomoto Group to Participate in the“Recovery of Degraded Pasture Verification Study”Project in Cooperation with Japanese Government Assistance Program for Brazil

• Mar 24th, 2025

  Ajinomoto Co.,Inc. Invests in Surgical Nutrition Startup Enhanced Medical Nutrition Inc.

• Mar 3rd, 2025

  Notice of Amendment to Number of Shares, etc. to be Increased by the Stock Split

• Mar 3rd, 2025

  Notice of Cancellation of Treasury Shares(Cancellation of treasury shares pursuant to the provisions of Article 178 of the Companies Act)

February

• Feb 12th, 2025

  Ajinomoto Co., Inc Announces Changes in Its Organization and Personnel

• Feb 12th, 2025

  Ajinomoto Co., Inc. Announces the Group’s Personnel Changes

• Feb 3rd, 2025

  Ajinomoto Co., Inc. Announces Executive Personnel Changes of President and Executive Officers

• Feb 3rd, 2025

  Ajinomoto Co., Inc. Announces Its Decision of Candidates for Members of the Board

• Feb 3rd, 2025

  Financial Statements for the Nine-Month Results for the Fiscal Year Ending March 31, 2025

January

• Jan 29th, 2025

  Notice of Share Repurchase and Program Completion (Share repurchase based on the regulation of the Articles of Incorporation pursuant to the provisions of Article 165-2 of the Companies Act)